Kyung Nam Pharm Co., Ltd. (053950) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Kyung Nam Pharm Co., Ltd. (053950:KRX), powered by AI.

Current Price
₩2,015
P/E Ratio
-3.5
Market Cap
31.5B
Sector
Common Stock
What is the Kyung Nam Pharm Co., Ltd. stock price forecast?

Kyung Nam Pharm Co., Ltd. is currently trading at ₩2,015. View real-time AI analysis on Alpha Lenz.

What is Kyung Nam Pharm Co., Ltd. insider trading activity?

View the latest insider trading data for Kyung Nam Pharm Co., Ltd. on Alpha Lenz.

What is Kyung Nam Pharm Co., Ltd.'s P/E ratio?

Kyung Nam Pharm Co., Ltd.'s P/E ratio is -3.5.

Kyung Nam Pharm Co., Ltd.

KRX · 053950
₩2,015+52(+2.65%)Market closedKRX regular session 09:00–15:30 KST
Ask about Kyung Nam Pharm Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Kyung Nam Pharm Co., Ltd. trades at a P/E of -3.5 (undervalued) with modest ROE of -8.1%.

Ask for details

Company Overview

Kyung Nam Pharm Co., Ltd. is a distinguished pharmaceutical company engaged in the manufacture and distribution of a broad array of healthcare products. Its primary function is to develop therapeutic solutions that cater to a wide range of medical needs, including pain management, cardiovascular health, and gastrointestinal wellbeing. The company plays a significant role in the healthcare sector, not only through its production of high-quality pharmaceuticals but also via its active research and development initiatives aimed at innovating new drugs and health supplements. With facilities equipped to meet international safety and quality standards, Kyung Nam Pharm Co., Ltd. serves both domestic and global markets, reinforcing its position in the pharmaceutical industry. Its impact is substantial in promoting public health and advancing medical science, making it a notable player in supporting healthcare systems and contributing to broader wellness objectives.

CEO김성곤, 조정영 (각자 대표이사)
SectorCommon Stock
IndustryCommon Stock
0

Company Statistics

FY 2025

Profile

₩31,493,384,065Market Cap
₩55,944,199,110Revenue
15.63MShares Out
0Employees

Margins

27.07%Gross
-1.95%EBITDA
-3.10%Operating
-15.48%Pre-Tax
-16.10%Net

Valuation

-3.50P/E
0.29P/B
0.56EV/Sales
-55.94EV/EBITDA
-10.70P/FCF

Growth (CAGR)

-1.76%Rev 3Yr
-4.64%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-5.59%ROA
-8.06%ROE
-4.72%ROIC

Financial Health

₩6,254,383,430Cash & Cash Equivalents
₩41,076,248,110Net Debt
43.70%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Kyung Nam Pharm Co., Ltd. (ticker: 053950) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $31.5B.

The current price is ₩2,015 with a P/E ratio of -3.5x and P/B of 0.29x.

ROE is -8.06% and operating margin is -3.10%. Annual revenue is $55.9B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Kyung Nam Pharm Co., Ltd. (053950) Stock Forecast 2026 ₩2,015 — Price, Financials & Analyst Targets | Alpha Lenz